Detalhe da pesquisa
1.
A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration.
Cell
; 153(2): 389-401, 2013 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23582328
2.
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
Nature
; 592(7854): 450-456, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762733
3.
FGFR2 Inhibition in Cholangiocarcinoma.
Annu Rev Med
; 74: 293-306, 2023 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170665
4.
Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication.
Cell Mol Life Sci
; 81(1): 115, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436764
5.
A critical spotlight on the paradigms of FFPE-DNA sequencing.
Nucleic Acids Res
; 51(14): 7143-7162, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351572
6.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 25(5): 626-635, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697156
7.
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.
Br J Cancer
; 130(2): 233-241, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996507
8.
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
J Hepatol
; 80(3): 431-442, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37972660
9.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10391): 1853-1865, 2023 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075781
10.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Lancet
; 402(10408): 1133-1146, 2023 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499670
11.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
Gastroenterology
; 164(1): 72-88.e18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108710
12.
Adjuvant and neoadjuvant therapies for hepatocellular carcinoma.
Hepatology
; 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108634
13.
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors.
Future Oncol
; 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214149
14.
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut
; 72(2): 381-391, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788059
15.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Lancet Oncol
; 24(12): 1411-1422, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951222
16.
'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?
Br J Cancer
; 128(9): 1665-1671, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807338
17.
Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma.
J Hepatol
; 78(3): 614-626, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528236
18.
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
J Hepatol
; 78(1): 133-141, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36341767
19.
Hepatocellular carcinoma.
Lancet
; 400(10360): 1345-1362, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084663
20.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology
; 76(4): 1000-1012, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313048